Test Announcement for COVID-19
CLIA certified laboratory that utilizes advanced RT-PCR based platforms.
Unrivaled precision and care
Prism Molecular is a CLIA certified laboratory that utilizes advanced RT-PCR based platforms including Open array technology to perform molecular testing. Multiplex PCR technology is a high-throughput method that allows us to simultaneously process multiple samples in the shortest possible time. Currently, Prism Molecular s is providing molecular testing solutions for infectious disease identification including the respiratory tract, urinary tract, sexual health, nail wound and antimicrobial resistance panels. All panels cover a wide variety of pathogens and the panels are curated based on CDC, NIH, and available epidemiological data from proven sources.
The scientific staff at Prism Molecular consists of several doctorate scholars, supervisors, and technologists with relevant postgraduate degrees. Our employment criteria is programmed to create a pool of scientists and technologists passionate about innovating diagnostic tests for patients and efficiently performing daily testing for our patients. Unlike other laboratories, Prism Molecular has a robust internal mechanism of confirming rest results for each patient sample which involves multiple replicates and layered analysis involving automated software and human inputs. Since inception, Prism Molecular focuses on rapid results without compromising the quality of testing. Utilizing software and automated processes efficiently has helped us instill this quality into our workflow.
Prism Molecular also provides pharmacogenetic testing solutions for patients. Pharmacogenetic testing may be used to:
- Find out whether a certain medicine could be effective for you
- Find out what the best dosage might be for you
- Predict whether you will have a serious side effect from a medicine
The Prism Approach
Prism Molecular utilizes real-time PCR technology which is a very sensitive and accurate technique for detecting pathogens and antibiotic resistance gene markers. This technique involves a single step detection method by rapidly amplifying a specific target segment of the pathogenʼs DNA/RNA. In each PCR reaction, the unique target DNA fragment is amplified into billions of copies that results in pathogen and antibiotic resistance marker gene recognition.
Accessibility is a key priority
Prism Molecular is dedicated to providing accurate, actionable, accessible, and timely results for infectious disease testing. The company offers a range of infectious disease testing services, including COVID-19 testing, and uses advanced technologies to provide reliable results.
Accuracy is a top priority for Prism Molecular, and the company has implemented stringent quality control measures to ensure that its results are highly accurate. The company’s testing processes are designed to minimize the risk of false positives and false negatives, and its staff are highly trained in handling and analyzing samples.
Prism Molecular also recognizes the importance of providing actionable results that can be used to inform clinical decision-making. The company’s testing reports are designed to be easy to understand and interpret, and its staff are available to provide guidance and support to healthcare providers and patients as needed.
COVID-19 pandemic has impacted the world in significant ways
Worldwide Statistics
Credentials
